Show of Hands

New drug. Rare bone cancer. In patients that saw results it was a cure. FDA rejects drug because they were miffed that they did not approve the trial. Europe approves drug in 30 countries and wins prestigious award for new drug.

Bad FDA Good FDA

9 Liked